Antiangiogenesis and drug delivery to tumors: bench to bedside and back

Cancer Research
Dan G Duda

Abstract

After over 30 years of preclinical and clinical development, antiangiogenic agents have recently entered the clinic as attractive targeted therapeutics for the treatment of cancer. Fueled by exciting new developments in the field, the AACR Special Conference was designed to broadly survey critical scientific advances in the antiangiogenic therapy of cancer. Because these advances have come primarily with the use of combinations of antiangiogenic agents with chemotherapy, or with antiangiogenic agents that also directly target the cancer cells, the central theme included the issue of drug delivery to tumors. These two major issues were addressed in concert, from basic mechanisms of action of antiangiogenic agents to new combination approaches to cancer treatment. Nearly 300 participants from 20 countries registered for the conference, drawn both from academia and industry, with a wide range in experience and background. Dr. Rakesh Jain, along with conference co-chairs, Drs. Lee Ellis and Luisa Iruela-Arispe, assembled an outstanding lineup of speakers for this conference that included many of the pioneers in the fields of angiogenesis and drug delivery from the U.S. and abroad. This resulted in an excellent overview of the advan...Continue Reading

References

Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Oct 2, 2003·Nature Biotechnology·David A LaVanRobert Langer
Feb 20, 2004·Nature·Timothy P PaderaRakesh K Jain
Feb 26, 2004·Nature Medicine·Ronit Satchi-FainaroJudah Folkman
Apr 2, 2004·Nature·Robert Langer, David A Tirrell
Jun 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Pirjo LaakkonenErkki Ruoslahti
Nov 3, 2004·Cancer Research·Belinda S ParkerStephen L Madden
Nov 19, 2004·Cancer Research·Kyoko HidaMichael Klagsbrun
Mar 16, 2005·Cancer Cell·Ronit Satchi-FainaroJudah Folkman
May 5, 2005·British Journal of Cancer·M O LeachUNKNOWN Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee, Drug Development Office, Cancer Research UK
May 17, 2005·Experimental and Molecular Pathology·Shu-Ching Shih, Lois E H Smith
May 25, 2005·The Journal of Cell Biology·Sunyoung LeeM Luisa Iruela-Arispe
Jul 15, 2005·Nature·Peter Carmeliet, Marc Tessier-Lavigne
Jul 27, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jun YuWilliam C Sessa
Aug 24, 2005·Nature Medicine·Annelii NyPeter Carmeliet
Sep 21, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Tomomi KambaDonald M McDonald
Sep 24, 2005·Nature·Sara M Weis, David A Cheresh
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G WillettGregory Y Lauwers
Jan 13, 2006·Nature Clinical Practice. Oncology·Rakesh K JainJay S Loeffler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Journal of the American College of Cardiology
Brendan Doyle, Noel Caplice
Trends in Pharmacological Sciences
Angelika KuehbacherStefanie Dimmeler
Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine
W S KerwinT S Hatsukami
© 2022 Meta ULC. All rights reserved